Clinical Trial Update: A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating MHB036C in combination with anti-tumor therapies for advanced lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• MHB036C

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Advanced Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING